AngioDynamics, Inc. 8-K Filing Report: Key Updates for Investors

Here are the key details extracted from the provided financial report section:

1. Filing Information:

• Filing Type: 8-K
• Filing Date: January 8, 2025

2. Company Information:

• Company Name: AngioDynamics, Inc.
• Company CIK: 0001275187
• Company IRS Employer Identification Number (EIN): 11-3146460
• State of Incorporation: Delaware (DE)
• Company Address: 14 Plaza Drive, Latham, NY 12110
• Phone Number: 518-795-1400

3. Ticker Symbol:

• Common Stock Ticker: ANGO
• Exchange: NASDAQ

4. Stock Information:

• Par Value: $0.01 per share

5. Context Information:

• Period: The reporting period starts and ends on January 8, 2025.

Insights:

• The filing is a Form 8-K, which typically indicates that the company is reporting a significant event that shareholders should be aware of. This could include events such as acquisitions, changes in management, or other material events.
• The report is specific to AngioDynamics, which operates in the medical device sector, suggesting that any significant events reported could be related to advancements in medical technology or regulatory updates.
• The filing is dated early in the year (January 8), which may indicate that it could relate to year-end activities or strategic initiatives for the upcoming year.

This information is crucial for investors or analysts who monitor AngioDynamics for potential impacts on stock performance or business strategy changes.